Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Lymphoma, also known as malignant lymphoma, is a general term for a group of malignant tumors originating from the lymphopoietic system. It is one of the most common tumors in China. In 2020, there were 544,352 new cases of non-Hodgkin lymphoma (NHL) worldwide, ranking 13th among all new cases of malignancies.

The global in vitro diagnostics market was valued at USD 55.00 million in 2016 and is projected to grow at a healthy CAGR of 5.60% between 2017 and 2025 to reach USD 89.8 million by the end of 2025. The market growth will be driven by the ri

Bio-Rad Laboratories has received clearance from the US Food and Drug Administration for its first liquid biopsy assay and Droplet Digital PCR system for diagnostic use, the firm announced today. The test is designed for monitoring treatment

BioMrieux announced today that it has acquired US-based food testing firm Invisible Sentinel for approximately $75 million to strengthen its position in food pathogen testing and spoilage organism detection. Invisible Sentinel said that its

Beckman Coulter Life Sciences announced today that it has acquired privately held liquid handling firm Labcyte. Based in San Jose, California, Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy f

Roche has agreed to acquire Spark Therapeutics for $4.8 billion cash, Spark said today, in a deal designed to expand the biopharma giant into gene therapy with the marketed Luxturna (voretigene neparvovec-rzyl) and a pipeline of other gene t

Indiana University School of Medicine researchers have developed a test to measure pain pain in patients. The hope is that such a test could help in the fight against opioid abuse. The study was led by Alexander Niculescu, MD, PhD and was pu

FDA published draft guidance on Feb. 25, 2019 on submission of bioavailability (BA) information for oral dosage drugs in investigation new drug applications (INDs), new drug applications (NDAs), and NDA supplements. In the guidance, FDA prov

A multi-partner collaboration between Oxford Genetics, Sphere Fluidics, the University of Edinburgh, and Twist Bioscience has been announced, which will target the acceleration of the development of automated microfluidic systems for rapid a

GE has agreed to sell its BioPharma business to Danaher Corporation for $21.4 billion, adding biopharmaceutical research, development, and manufacturing instruments, equipment, and consumables to Danahers Life Science group, which includes P

C2N Diagnostics is experiencing a couple of breakthroughs with its Alzheimers disease detection test - one courtesy of FDA. The agency, which is slowly rising back to full strength after the temporary government shutdown, granted the St. Lou